Status:
UNKNOWN
RCT of CBT Combined With D-Cycloserine for Treating PTSD
Lead Sponsor:
Université de Montréal
Collaborating Sponsors:
Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal
Conditions:
Post-Traumatic Stress Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to investigate if the effectiveness of cognitive-behavioral therapy for post-traumatic stress disorder can be increased by combining it with D-cycloserine (TCC/D-cycloseri...
Detailed Description
Post-traumatic stress disorder (PTSD) is one of the most frequent anxiety disorder in the general population (Kessler and al., 2005). Currently, the treatment of choice for PTSD is cognitive-behaviora...
Eligibility Criteria
Inclusion
- Clinical diagnosis of PTSD
- No other Axix I disorder of higher intensity than PTSD
- Accept not to start a psychopharmacological treatment before and during the participation to the project
Exclusion
- Substance abuse
- Psychotic episodes (past or current)
- Bipolar disorder
- Organic caused mental disorder
- Intellectual deficiency
- Pregnant or breast-feeding woman
- Épilepsy
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
End Date :
July 1 2008
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00452231
Start Date
February 1 2007
End Date
July 1 2008
Last Update
March 27 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre d'étude sur le Trauma
Montreal, Quebec, Canada, H1N 3V2